Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)
Clinical trial NCT04439227 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04439227
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-24
- Primary completion
- 2020-05-29
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.